The MedX Executive Team is composed of professionals who have
experience in management, finance, manufacturing, research and development.
Steve Guillen, B.Sc., M.B.A.
Chief Executive Officer, President and Director
Louie Canitano B,Sc. (N.H.)
Executive Vice President of Operations
Steve Guillen, B.Sc., M.B.A. - Chief Executive Officer, President and Director – Mr. Guillen has spent over 30 years in the health care industry in both public and private medical technology companies, and has extensive experience in the areas of sales & marketing and mergers & acquisitions. Prior to joining MedX, Mr. Guillen was Chief Executive Officer of OXIS International, Inc, a publicly traded medical technology company with FDA approved and developmental stage products in the medical device, pharmaceutical and OTC markets. Prior to that, Mr. Guillen was, for eight years, Vice President of Sales & Marketing for Amarin Pharmaceuticals, and Athena Diagnostics. Mr. Guillen began his career in medical technology companies at Merck & Co., where he spent 17 years, and was Head of Management Training, before he was recruited to establish his first commercial organization at Athena Neurosciences as Director of Sales. Back to top
Louie Canitano B,Sc. (N.H.) - Executive Vice President of Operations - Mr. Canitano has over 15 years of operational Healthcare experience. Mr. Canitano has covered all sectors including Sales and Marketing, Regulatory, IP and, Design and Development. Mr. Canitano was also awarded Patent as the Co-Inventor: WO/2006/050608 Method, Apparatus And Protocols For Performing Low Level Laser Therapy. As Founder of several companies such as RJ Laser Canada and Laserceuticals, Mr. Canaitano was awarded distribution rights to the RJ Laser product line for Canada and the USA. Mr. Canitano obtained Health Canada and FDA approvals for several models and secured Eastern Currents as a major distributor. RJ Laser Canada and Laserceuticals was sold to MedX Health. Mr. Canitano began his career with managing several successful "G" Code and Schedule 5 OHIP physiotherapy clinics, introducing and utilizing laser therapy as a palliative modality. Of academic note, Mr. Canitano was a participant at the 5th Congress of the World Association for Laser Therapy (WALT) representing a sub-committee for industry. Back
to top
|
